The expected impact of the WELMO project is briefed along the following points:
New opportunities for business development by producing novel sustainable, cheap, wearable, electronic solutions in the field of healthcare as well as in other relative fields in need of continuous monitoring of vital signals (e.g. sports etc).
Strengthened scientific knowledge in the field of EIT technology beyond traditional perspectives.
Increased inference of data through simultaneous acquisition of multiple bio-signals (EIT and sound signals).
Reinforce medical knowledge and improved management of chronic respiratory conditions.
Strengthened evidence base on health outcomes, quality of life, care efficiency and economic benefits from the ICT interventions in the care models.
Empowering individuals to better manage their own condition.
Increased level of education and acceptance by patients and care givers of ICT solutions for personalised care.
Reduce rates of exacerbation and hospitalization days and increase effective professional assistance; Continuous monitoring and early intervention is the key to effective management of respiratory diseases.
Avoidance of patients’ re-admissions , directly reducing the annual cost of therapy related to respiratory chronic diseases,
Strengthened European industrial position in ICT for health products and medical devices.